Taylor MD - Search Results

1

Tumor recurrence after complete resection for non-small cell lung cancer.

Taylor MD, Nagji AS, Bhamidipati CM, Theodosakis N, Kozower BD, Lau CL, Jones DR. Taylor MD, et al. Ann Thorac Surg. 2012 Jun;93(6):1813-20; discussion 1820-1. doi: 10.1016/j.athoracsur.2012.03.031. Epub 2012 Apr 26. Ann Thorac Surg. 2012. PMID: 22542070

2

Quality of life following primary vs. redo transthoracic paraesophageal hernia repairs.

Taylor MD, Nagji AS, Kozower BD, Shami VM, Daniel TM, Jones DR. Taylor MD, et al. Interact Cardiovasc Thorac Surg. 2008 Feb;7(1):71-4. doi: 10.1510/icvts.2007.163741. Epub 2007 Nov 13. Interact Cardiovasc Thorac Surg. 2008. PMID: 18000023

3

Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancer.

Taylor MD, Smith PW, Brix WK, Wick MR, Theodosakis N, Swenson BR, Kozower BD, Jones DR. Taylor MD, et al. Eur J Cardiothorac Surg. 2009 Apr;35(4):699-705. doi: 10.1016/j.ejcts.2008.11.029. Epub 2009 Jan 10. Eur J Cardiothorac Surg. 2009. PMID: 19136271 Free PMC article.

4

Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.

Taylor MD, Smith PW, Brix WK, Wick MR, Theodosakis N, Swenson BR, Kozower BD, Lau CL, Jones DR. Taylor MD, et al. J Thorac Cardiovasc Surg. 2009 Jan;137(1):43-8. doi: 10.1016/j.jtcvs.2008.10.014. J Thorac Cardiovasc Surg. 2009. PMID: 19154901 Free PMC article.

5

Genetic markers of mediastinal tumors.

Taylor MD, Jones DR. Taylor MD, et al. Thorac Surg Clin. 2009 Feb;19(1):17-27. doi: 10.1016/j.thorsurg.2008.09.004. Thorac Surg Clin. 2009. PMID: 19288817 Review.

6

Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion.

Jones DR, Taylor MD, Petroni GR, Shu J, Burks SG, Daniel TM, Gillenwater HH. Jones DR, et al. Among authors: taylor md. J Thorac Oncol. 2010 Jan;5(1):75-81. doi: 10.1097/JTO.0b013e3181c07ddc. J Thorac Oncol. 2010. PMID: 19884858 Free article. Clinical Trial.

7

Combined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cells.

Taylor MD, Liu Y, Nagji AS, Theodosakis N, Jones DR. Taylor MD, et al. J Thorac Cardiovasc Surg. 2010 May;139(5):1224-32, 1232.e1. doi: 10.1016/j.jtcvs.2010.01.039. J Thorac Cardiovasc Surg. 2010. PMID: 20412959 Free PMC article.

8

Surgical spectrum in the management of empyemas.

Taylor MD, Kozower BD. Taylor MD, et al. Thorac Surg Clin. 2012 Aug;22(3):431-40. doi: 10.1016/j.thorsurg.2012.04.007. Epub 2012 Jun 12. Thorac Surg Clin. 2012. PMID: 22789604 Review.

9

Induction chemoradiotherapy and surgery for esophageal cancer: survival benefit with downstaging.

Taylor MD, LaPar DJ, Davis JP, Isbell JM, Kozower BD, Lau CL, Jones DR. Taylor MD, et al. Ann Thorac Surg. 2013 Jul;96(1):225-30: discussion 230-1. doi: 10.1016/j.athoracsur.2013.01.074. Epub 2013 Apr 22. Ann Thorac Surg. 2013. PMID: 23618518

10

Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.

Taylor MD, LaPar DJ, Thomas CJ, Persinger M, Stelow EB, Kozower BD, Lau CL, Jones DR. Taylor MD, et al. Ann Thorac Surg. 2013 Oct;96(4):1163-1170. doi: 10.1016/j.athoracsur.2013.04.031. Epub 2013 Aug 30. Ann Thorac Surg. 2013. PMID: 23998409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

915 results

Search Page

Filters